Johnson & Johnson vs Bristol Myers Squibb vs Viatris and 1 More Revenue Comparison
Compare financial metrics side-by-side using real SEC EDGAR data
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Johnson & Johnson 25.31, Bristol Myers Squibb 12.973, Viatris 3.757, Zoetis 2.468.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Johnson & Johnson, Bristol Myers Squibb, Viatris, Zoetis.| Metric | Johnson & Johnson | Bristol Myers Squibb | Viatris | Zoetis |
|---|---|---|---|---|
| Market Cap | $650.67B | $138.03B | $19.35B | $32.03B |
| Revenue | $25.31B | $12.97B | $3.76B | $2.47B |
| Cost of Revenue | $6.81B | $3.73B | $2.30B | $673.00M |
| Gross Profit | $18.50B | $9.25B | $1.46B | $1.79B |
| Operating Income | $7.17B | $4.09B | $6.00M | $937.00M |
| Net Income | $5.53B | $3.32B | $-119.00M | $691.00M |
| R&D Expense | $3.65B | $2.96B | $248.00M | $173.00M |
| Earnings Per Share | $2.27 | $1.62 | -$0.1 | $1.65 |
| Gross Margin | 73.1% | 71.3% | 38.8% | 72.7% |
| Operating Margin | 28.3% | 31.5% | 0.2% | 38.0% |
| Net Profit Margin | 21.9% | 25.6% | -3.2% | 28.0% |
| Free Cash Flow | $3.39B | $3.09B | $329.00M | $538.00M |
| Cumulative Free Cash Flow | $383.40B | $168.10B | $22.87B | $18.23B |
| Operating Cash Flow | $4.71B | $3.39B | $382.00M | $655.00M |
| Cash & Equivalents | $20.42B | $8.72B | $886.00M | $1.48B |